IN2014DN00123A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN00123A IN2014DN00123A IN123DEN2014A IN2014DN00123A IN 2014DN00123 A IN2014DN00123 A IN 2014DN00123A IN 123DEN2014 A IN123DEN2014 A IN 123DEN2014A IN 2014DN00123 A IN2014DN00123 A IN 2014DN00123A
- Authority
- IN
- India
- Prior art keywords
- compounds
- mek
- inflammation
- inhibitors
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
The present invention relates to compounds (I) and pharmaceutically acceptable salts thereof. The compounds have been demonstrated as inhibitors of MEK and therefore may be useful in the treatment of hyperproliferative diseases like cancer and inflammation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN123DEN2014 IN2014DN00123A (en) | 2011-06-09 | 2012-06-06 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1634DE2011 | 2011-06-09 | ||
CN201210175145 | 2012-05-31 | ||
PCT/IB2012/052860 WO2012168884A1 (en) | 2011-06-09 | 2012-06-06 | Heterocyclic sulfonamide derivatives |
IN123DEN2014 IN2014DN00123A (en) | 2011-06-09 | 2012-06-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN00123A true IN2014DN00123A (en) | 2015-05-22 |
Family
ID=46384435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN123DEN2014 IN2014DN00123A (en) | 2011-06-09 | 2012-06-06 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2718276A1 (en) |
JP (1) | JP2014517004A (en) |
KR (1) | KR20140034898A (en) |
AU (1) | AU2012265844A1 (en) |
BR (1) | BR112013031201A2 (en) |
CA (1) | CA2838029A1 (en) |
EA (1) | EA201391820A1 (en) |
IN (1) | IN2014DN00123A (en) |
MX (1) | MX2013014398A (en) |
WO (1) | WO2012168884A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013094546A1 (en) * | 2011-12-19 | 2013-06-27 | 住友化学株式会社 | Method for producing sulfonate |
EP3251673A1 (en) | 2012-12-13 | 2017-12-06 | IP Gesellschaft für Management mbH | Combination therapy comprising a cdk4/6 inhibitor and a pi3k inhibitor for use in the treatment of cancer |
CN104886052B (en) * | 2015-06-02 | 2016-08-31 | 吉林省八达农药有限公司 | A kind of application of cyclopropyl-sulfonylamide |
EP3630746A1 (en) * | 2017-05-25 | 2020-04-08 | Araxes Pharma LLC | Compounds and methods of use thereof for treatment of cancer |
WO2019183385A1 (en) * | 2018-03-22 | 2019-09-26 | University Of Rochester | Mapk/erk inhibition for ovarian and other cancers |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR901228A (en) | 1943-01-16 | 1945-07-20 | Deutsche Edelstahlwerke Ag | Ring gap magnet system |
GB1524747A (en) | 1976-05-11 | 1978-09-13 | Ici Ltd | Polypeptide |
ATE28864T1 (en) | 1982-07-23 | 1987-08-15 | Ici Plc | AMIDE DERIVATIVES. |
GB8327256D0 (en) | 1983-10-12 | 1983-11-16 | Ici Plc | Steroid derivatives |
US5093330A (en) | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
US5010099A (en) | 1989-08-11 | 1991-04-23 | Harbor Branch Oceanographic Institution, Inc. | Discodermolide compounds, compositions containing same and method of preparation and use |
US5395855A (en) | 1990-05-07 | 1995-03-07 | Ciba-Geigy Corporation | Hydrazones |
NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
GB9300059D0 (en) | 1992-01-20 | 1993-03-03 | Zeneca Ltd | Quinazoline derivatives |
TW225528B (en) | 1992-04-03 | 1994-06-21 | Ciba Geigy Ag | |
ATE348110T1 (en) | 1992-10-28 | 2007-01-15 | Genentech Inc | HVEGF RECEPTOR AS A VEGF ANTAGONIST |
GB9314893D0 (en) | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
EP2163546B1 (en) | 1995-03-30 | 2016-06-01 | Pfizer Products Inc. | Quinazoline derivatives |
GB9508538D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
US5843901A (en) | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
US5880141A (en) | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
BR9609617B1 (en) | 1995-07-06 | 2010-07-27 | 7h-pyrrol [2,3-d] pyrimidine derivatives, and pharmaceutical composition. | |
US5760041A (en) | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
BR9708640B1 (en) | 1996-04-12 | 2013-06-11 | irreversible tyrosine kinase inhibitors and pharmaceutical composition comprising them. | |
EP0907642B1 (en) | 1996-06-24 | 2005-11-02 | Pfizer Inc. | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases |
AU716610B2 (en) | 1996-08-30 | 2000-03-02 | Novartis Ag | Method for producing epothilones, and intermediate products obtained during the production process |
JP2002513445A (en) | 1996-09-06 | 2002-05-08 | オブデュキャット、アクチボラグ | Method for anisotropically etching structures in conductive materials |
DE19638745C2 (en) | 1996-09-11 | 2001-05-10 | Schering Ag | Monoclonal antibodies against the extracellular domain of the human VEGF receptor protein (KDR) |
AU4342997A (en) | 1996-09-13 | 1998-04-02 | Sugen, Inc. | Use of quinazoline derivatives for the manufacture of a medicament in the reatment of hyperproliferative skin disorders |
EP0837063A1 (en) | 1996-10-17 | 1998-04-22 | Pfizer Inc. | 4-Aminoquinazoline derivatives |
JP4274583B2 (en) | 1996-11-18 | 2009-06-10 | ゲゼルシャフト・フュア・ビオテクノロギッシェ・フォルシュンク・ミット・ベシュレンクテル・ハフツング(ゲー・ベー・エフ) | Epothilone C, D, E and F, manufacturing and drugs |
US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
CO4950519A1 (en) | 1997-02-13 | 2000-09-01 | Novartis Ag | PHTHALAZINES, PHARMACEUTICAL PREPARATIONS THAT UNDERSTAND THEM AND THE PROCESS FOR THEIR PREPARATION |
CO4940418A1 (en) | 1997-07-18 | 2000-07-24 | Novartis Ag | MODIFICATION OF A CRYSTAL OF A DERIVATIVE OF N-PHENYL-2-PIRIMIDINAMINE, PROCESSES FOR ITS MANUFACTURE AND USE |
GB9721069D0 (en) | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Polymeric derivatives of camptothecin |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
NZ506742A (en) | 1998-02-25 | 2003-09-26 | Sloan Kettering Inst Cancer | Synthesis of desoxyepothilones and hydroxy acid derivative intermediates |
ES2342240T3 (en) | 1998-08-11 | 2010-07-02 | Novartis Ag | ISOQUINOLINE DERIVATIVES WITH ACTIVITY INHIBITED BY ANGIOGENIA. |
GB9824579D0 (en) | 1998-11-10 | 1999-01-06 | Novartis Ag | Organic compounds |
UA71587C2 (en) | 1998-11-10 | 2004-12-15 | Шерінг Акцієнгезелльшафт | Anthranilic acid amides and use thereof as medicaments |
US6303342B1 (en) | 1998-11-20 | 2001-10-16 | Kason Biosciences, Inc. | Recombinant methods and materials for producing epothilones C and D |
ATE300957T1 (en) | 1998-12-22 | 2005-08-15 | Genentech Inc | ANTAGONISTS OF VASCULAR-ENDOTHELIAL CELL GROWTH FACTORS AND THEIR APPLICATION |
CN1221262C (en) | 1999-03-30 | 2005-10-05 | 诺瓦提斯公司 | Phthalazine derivatives for treating inflammatory diseases |
PE20020354A1 (en) | 2000-09-01 | 2002-06-12 | Novartis Ag | HYDROXAMATE COMPOUNDS AS HISTONE-DESACETILASE (HDA) INHIBITORS |
TWI238824B (en) | 2001-05-14 | 2005-09-01 | Novartis Ag | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives |
GB0119249D0 (en) | 2001-08-07 | 2001-10-03 | Novartis Ag | Organic compounds |
JP2006083137A (en) * | 2004-09-17 | 2006-03-30 | Sankyo Co Ltd | Immunosuppressive agent |
EA200900959A1 (en) * | 2007-01-19 | 2010-02-26 | Арди Байосайенсиз, Инк. | MEK INHIBITORS |
JP5479337B2 (en) * | 2007-07-30 | 2014-04-23 | アルディア バイオサイエンス,インク. | Combination of MEK inhibitor and RAF kinase inhibitor and use thereof |
CA2717529A1 (en) * | 2008-03-11 | 2009-09-17 | Cellzome Limited | Sulfonamides as zap-70 inhibitors |
US8841462B2 (en) * | 2008-07-01 | 2014-09-23 | Robert A. Heald | Bicyclic heterocycles as MEK kinase inhibitors |
CA2761108A1 (en) * | 2009-04-21 | 2010-10-28 | Novartis Ag | Heterocyclic compounds as mek inhibitors |
CN102134218A (en) * | 2009-06-15 | 2011-07-27 | 凯美隆(北京)药业技术有限公司 | 6-aryl amino pyridone sulfamide and 6-aryl amino pymetrozine sulfamide methyl ethyl ketone (MEK) inihibitor |
AU2010317167B2 (en) * | 2009-11-04 | 2012-11-29 | Novartis Ag | Heterocyclic sulfonamide derivatives useful as MEK inhibitors |
EP2509964B1 (en) * | 2009-12-08 | 2014-04-30 | Novartis AG | Heterocyclic sulfonamide derivatives |
-
2012
- 2012-06-06 EA EA201391820A patent/EA201391820A1/en unknown
- 2012-06-06 AU AU2012265844A patent/AU2012265844A1/en not_active Abandoned
- 2012-06-06 KR KR1020147000283A patent/KR20140034898A/en not_active Application Discontinuation
- 2012-06-06 JP JP2014514204A patent/JP2014517004A/en active Pending
- 2012-06-06 IN IN123DEN2014 patent/IN2014DN00123A/en unknown
- 2012-06-06 WO PCT/IB2012/052860 patent/WO2012168884A1/en active Application Filing
- 2012-06-06 EP EP12730043.2A patent/EP2718276A1/en not_active Withdrawn
- 2012-06-06 MX MX2013014398A patent/MX2013014398A/en unknown
- 2012-06-06 CA CA2838029A patent/CA2838029A1/en not_active Abandoned
- 2012-06-06 BR BR112013031201A patent/BR112013031201A2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MX2013014398A (en) | 2014-03-21 |
CA2838029A1 (en) | 2012-12-13 |
WO2012168884A1 (en) | 2012-12-13 |
JP2014517004A (en) | 2014-07-17 |
AU2012265844A1 (en) | 2013-05-02 |
EP2718276A1 (en) | 2014-04-16 |
EA201391820A1 (en) | 2014-12-30 |
KR20140034898A (en) | 2014-03-20 |
BR112013031201A2 (en) | 2017-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014028600A3 (en) | 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | |
AU2012214029A8 (en) | Rorgammat inhibitors | |
IN2015DN01156A (en) | ||
PH12014501561A1 (en) | Therapeutically active compounds and their methods of use | |
IN2014KN00769A (en) | ||
CR20200479A (en) | Therapeutically active compounds and their methods of use | |
MX2011011083A (en) | Heterocyclic compounds as mek inhibitors. | |
TN2012000465A1 (en) | Derivatives of 1-amino-2-cyclopropylethylboronic acid | |
IN2014MN00948A (en) | ||
MX349159B (en) | Deuterated derivatives of ivacaftor. | |
EP2750694B8 (en) | Methods and compositions relating to p62 for the treatment and prophylaxis of cancer | |
IN2014MN00987A (en) | ||
IN2015DN01119A (en) | ||
PH12014501829A1 (en) | Bicyclic pyrazinone derivatives | |
MX348726B (en) | Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation. | |
MX353762B (en) | Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation. | |
WO2015003355A3 (en) | Therapeutically active compounds and their methods of use | |
MX2013012977A (en) | Thiazole derivatives. | |
MX2014003376A (en) | Benzoic acid derivatives as eif4e inhibitors. | |
EA032271B9 (en) | Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases | |
IN2014DN00123A (en) | ||
TN2012000242A1 (en) | Heterocyclic sulfonamide derivatives | |
MX2015007945A (en) | Uses and methods for the treatment of liver diseases or conditions. | |
IN2014DN03010A (en) | ||
MX348147B (en) | Bisarylsulfonamides useful in the treatment of inflammation and cancer. |